These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9075707)

  • 21. Vitamin D3-retinoid X receptor dimerization, DNA binding, and transactivation are differentially affected by analogs of 1,25-dihydroxyvitamin D3.
    Cheskis B; Lemon BD; Uskokovic M; Lomedico PT; Freedman LP
    Mol Endocrinol; 1995 Dec; 9(12):1814-24. PubMed ID: 8614417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of nuclear receptor interactions by ligands: kinetic analysis using surface plasmon resonance.
    Cheskis B; Freedman LP
    Biochemistry; 1996 Mar; 35(10):3309-18. PubMed ID: 8605168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of HL60 cells with various combinations of retinoids and 1 alpha,25 dihydroxyvitamin D3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis.
    Bunce CM; Wallington LA; Harrison P; Williams GR; Brown G
    Leukemia; 1995 Mar; 9(3):410-8. PubMed ID: 7885039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. All-trans retinoic acid and 1 alpha,25-dihydroxyvitamin D3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes.
    Brown G; Bunce CM; Rowlands DC; Williams GR
    Leukemia; 1994 May; 8(5):806-15. PubMed ID: 8182938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
    Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
    Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid.
    Wu S; Zhang D; Zhang ZP; Soprano DR; Soprano KJ
    Oncogene; 1998 Dec; 17(22):2839-49. PubMed ID: 9879990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells.
    Zugmaier G; Jäger R; Grage B; Gottardis MM; Havemann K; Knabbe C
    Br J Cancer; 1996 Jun; 73(11):1341-6. PubMed ID: 8645577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic inhibition of prostate cancer cell lines by a 19-nor hexafluoride vitamin D3 analogue and anti-activator protein 1 retinoid.
    Campbell MJ; Park S; Uskokovic MR; Dawson MI; Jong L; Koeffler HP
    Br J Cancer; 1999 Jan; 79(1):101-7. PubMed ID: 10408700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells.
    Zhao Z; Zhang ZP; Soprano DR; Soprano KJ
    Exp Cell Res; 1995 Aug; 219(2):555-61. PubMed ID: 7641808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
    Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
    Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
    Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C
    J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
    Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two distinct actions of retinoid-receptor ligands.
    Chen JY; Clifford J; Zusi C; Starrett J; Tortolani D; Ostrowski J; Reczek PR; Chambon P; Gronemeyer H
    Nature; 1996 Aug; 382(6594):819-22. PubMed ID: 8752277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.
    Higashimoto Y; Ohata M; Nishio K; Iwamoto Y; Fujimoto H; Uetani K; Suruda T; Nakamura Y; Funasako M; Saijo N
    Anticancer Res; 1996; 16(5A):2653-9. PubMed ID: 8917365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
    Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
    Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 9-cis retinoic acid antagonizes the stimulatory effect of 1,25 dihydroxyvitamin D3 on chondrogenesis of chick limb bud mesenchymal cells: interactions of their receptors.
    Tsonis PA; Sargent MT; Del Rio-Tsonis K; Jung JC
    Int J Dev Biol; 1996 Oct; 40(5):1053-9. PubMed ID: 8946252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liarozole acts synergistically with 1alpha,25-dihydroxyvitamin D3 to inhibit growth of DU 145 human prostate cancer cells by blocking 24-hydroxylase activity.
    Ly LH; Zhao XY; Holloway L; Feldman D
    Endocrinology; 1999 May; 140(5):2071-6. PubMed ID: 10218956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular evaluation of vitamin D3 receptor agonists designed for topical treatment of skin diseases.
    Bury Y; Ruf D; Hansen CM; Kissmeyer AM; Binderup L; Carlberg C
    J Invest Dermatol; 2001 May; 116(5):785-92. PubMed ID: 11348471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.